Strategic Report Governance Financial Statements Other Information Consolidated statements of income In millions of US dollars, except share and per share data 2015 2014 Year to December 31, Notes $M $M Revenues: Product sales 6,099.9 5,830.4 Royalties 300.5 160.8 Other revenues 16.3 30.9 Total revenues 6,416.7 6,022.1 Costs and expenses: Cost of product sales 969.0 979.3 1 Research and development 1,564.0 1,067.5 1 Selling, general and administrative 2,341.2 2,025.8 Goodwill impairment charge 9 Gain on sale of product rights 14.7 88.2 Reorganization costs 5 97.9 180.9 Integration and acquisition costs 6 39.8 158.8 Total operating expenses 4,997.2 4,324.1 Operating income from continuing operations 1,419.5 1,698.0 Interest income 4.2 24.7 Interest expense 41.6 30.8 Other income expense, net 3.7 8.9 Receipt of break fee 25 1,635.4 Income from continuing operations before income taxes and equity in losses earnings of equity method investees 1,385.8 3,336.2 Income taxes 27 46.1 56.1 Equity in losses earnings of equity method investees, net of taxes 2.2 2.7 Income from continuing operations, net of taxes 1,337.5 3,282.8 Loss gain from discontinued operations, net of taxes 9 34.1 122.7 Net income 1,303.4 3,405.5 Earnings per ordinary share basic Earnings from continuing operations 226.5 559.6 Loss gain from discontinued operations 5.8 20.9 Earnings per ordinary share basic 220.7 580.5 Earnings per ordinary share diluted Earnings from continuing operations 225.5 555.2 Loss gain from discontinued operations 5.8 20.8 Earnings per ordinary share diluted 219.7 576.0 Weighted average number of shares millions : Basic 22 590.4 586.7 Diluted 22 593.1 591.3 1 Research and development R&D includes IPR&D intangible asset impairment charges of $643.7million for the year to December 31, 2015 2014: $190.3million.
Selling, general and administrative SG&A costs include amortization of intangible assets relating to intellectual property rights acquired of $498.7million for the year to December 31, 2015 2014: $243.8million.
The accompanying notes are an integral part of these consolidated financial statements.
